Senior Principal Scientist
Designed, conducted, analyzed and reported more than 200 pharmacokinetic, ADME, toxicokinetic and drug metabolism studies of small molecules and biologics. Conducted or supervised/monitored all the nonclinical PK/TK/ADME studies for the empagliflozin submission. Represented DMPK on project teams, and served as study monitor on contracted studies. Wrote DMPK sections of INDs, Investigator’s Brochures, IND updates, IBs, and NDAs. Was the main DMPK scientist evaluating in-licensing… Show more Designed, conducted, analyzed and reported more than 200 pharmacokinetic, ADME, toxicokinetic and drug metabolism studies of small molecules and biologics. Conducted or supervised/monitored all the nonclinical PK/TK/ADME studies for the empagliflozin submission. Represented DMPK on project teams, and served as study monitor on contracted studies. Wrote DMPK sections of INDs, Investigator’s Brochures, IND updates, IBs, and NDAs. Was the main DMPK scientist evaluating in-licensing opportunities. Served on the human PK prediction and metabolite profiling and identification expert groups. Show less
